Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacotherapy for cataplexy.

William C Houghton1, Thomas E Scammell, Michael Thorpy

  • 1Orphan Medical, Inc., Medical Affairs, 13911 Ridgedale Drive, Suite 250, Minnetonka, MN 55305, USA. whoughton@orphan.com

Sleep Medicine Reviews
|September 1, 2004
PubMed
Summary

Several drug classes, including aminergic reuptake inhibitors and sodium oxybate, effectively treat cataplexy in narcolepsy patients. This review details their safety and efficacy for optimizing clinical management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oxytocin promotes socially triggered cataplexy.

Nature neuroscience·2026
Same author

Reply to "The question of whether narcolepsy increases mortality should be answered based on reliable studies".

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Reply to "Veteran status as an underappreciated confound in narcolepsy mortality".

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Mortality in narcolepsy and other sleep clinic patients: a 25-year propensity-matched VA cohort study.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine·2026
Same author

Effects of Oveporexton, an Orexin Receptor 2-Selective Agonist, on Cognition in Narcolepsy Type 1: A Secondary Analysis of a Randomized Clinical Trial.

JAMA neurology·2025
Same author

An orexin agonist promotes wakefulness and inhibits cataplexy through distinct brain regions.

Current biology : CB·2025

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Narcolepsy is a chronic neurological disorder characterized by excessive daytime sleepiness and sudden muscle weakness (cataplexy).
  • Cataplexy significantly impacts patient quality of life, necessitating effective treatment strategies.

Purpose of the Study:

  • To review the safety and efficacy of medications used to manage cataplexy in narcolepsy.
  • To provide clinicians with information to optimize cataplexy treatment.

Main Methods:

  • Literature review of major drug classes used for cataplexy.
  • Analysis of safety and efficacy data for specified medications.

Main Results:

  • Aminergic reuptake inhibitors (e.g., venlafaxine, clomipramine) are effective in reducing cataplexy.

Related Experiment Videos

  • Sodium oxybate also demonstrates efficacy in managing cataplexy symptoms.

    • Conclusions:

    • Multiple medication options exist for improving cataplexy in narcolepsy.
    • Understanding the safety and efficacy profiles is crucial for effective clinical management.